← Leaderboards
Charles Nicholas Serhan
Brigham And Women'S Hospital
$33,627,216
Attributed
$42,267,864
Total exposure
24
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$75,963,737 · 27
By mechanism
P01$31,377,209 · 11
R01$17,377,146 · 8
P50$16,322,234 · 4
R37$3,967,636 · 1
R35$3,584,466 · 1
RC2$2,824,336 · 1
Top collaborators
- Ru-Rong Ji7 shared
- Dipak Panigrahy7 shared
- Daniel Irimia4 shared
- Thomas E Van Dyke4 shared
- Bruce D Levy3 shared
- Nicolas Guillermo Bazan2 shared
- Philip Demokritou2 shared
- Steven David Freedman2 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Joshua A Boyce$54,050,346
- Karsten Gronert$6,688,446
- Stephania Libreros$1,149,525
- David M Lee$4,978,934
- Carolyn Louise Cannon$2,636,299
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationResolutionPathway InteractionsMediator Of Activation ProteinAcuteLipid MediatorNeutrophilCd59 AntigenProgramsAnti-Inflammatory AgentsAnti-InflammatoryTissuesMolecularHomeostasisMacrophageInflammatoryEicosanoidsMissionIn VivoFamilyResponseExudateInjurySignal Transduction
Grant awards (132)
Resolution of inflammation in chemical-induced cancer$749,474
R01 · FY2025 · CA
Evaluating Resolution Mechanisms for Infectious Inflammation$745,800
R35 · FY2025 · GM · contact PI
Traffic-Related Ultrafine Particles Disrupt The Resolution Of Lung Inflammation$692,585
R01 · FY2025 · HL
Control of cancer cachexia via stimulation of resolution of inflammation$691,696
R01 · FY2025 · CA
Evaluating Resolution Mechanisms for Infectious Inflammation$745,800
R35 · FY2024 · GM · contact PI
Traffic-Related Ultrafine Particles Disrupt The Resolution Of Lung Inflammation$732,085
R01 · FY2024 · HL
Control of cancer cachexia via stimulation of resolution of inflammation$709,923
R01 · FY2024 · CA
Evaluating Resolution Mechanisms for Infectious Inflammation$745,800
R35 · FY2023 · GM · contact PI
Evaluating Resolution Mechanisms for Infectious Inflammation$745,800
R35 · FY2022 · GM · contact PI
EPHEDRA: Enhanced PHthisic by Environmental Disruptors of Resolution Agonists$510,710
R56 · FY2022 · ES
Evaluating Resolution Mechanisms for Infectious Inflammation$601,266
R35 · FY2021 · GM · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,606,435
P01 · FY2020 · GM · contact PI
Blood Cell Lipoxygenase Products -- Formation and Action$430,310
R01 · FY2020 · GM · contact PI
Project 1: Novel Specialized Pro-Resolving Lipid Mediators (SPM) in Resolution of Acute Inflammation$379,151
P01 · FY2020 · GM · contact PI
Core B: Lipid Mediator-SPM Lipidomics$268,838
P01 · FY2020 · GM · contact PI
Advisory and Communications Core A$74,726
P01 · FY2020 · GM · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,606,435
P01 · FY2019 · GM · contact PI
Blood Cell Lipoxygenase Products -- Formation and Action$430,310
R01 · FY2019 · GM · contact PI
Project 1: Novel Specialized Pro-Resolving Lipid Mediators (SPM) in Resolution of Acute Inflammation$379,151
P01 · FY2019 · GM · contact PI
Core B: Lipid Mediator-SPM Lipidomics$268,838
P01 · FY2019 · GM · contact PI
Advisory and Communications Core A$74,726
P01 · FY2019 · GM · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,601,811
P01 · FY2018 · GM · contact PI
Blood Cell Lipoxygenase Products -- Formation and Action$430,310
R01 · FY2018 · GM · contact PI
Project 1: Novel Specialized Pro-Resolving Lipid Mediators (SPM) in Resolution of Acute Inflammation$337,086
P01 · FY2018 · GM · contact PI
Core B: Lipid Mediator-SPM Lipidomics$241,951
P01 · FY2018 · GM · contact PI
Advisory and Communications Core A$67,251
P01 · FY2018 · GM · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,579,295
P01 · FY2017 · GM · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$486,135
R01 · FY2017 · GM · contact PI
Project 1: Novel Specialized Pro-Resolving Lipid Mediators (SPM) in Resolution of Acute Inflammation$374,520
P01 · FY2017 · GM · contact PI
Core B: Lipid Mediator-SPM Lipidomics$246,377
P01 · FY2017 · GM · contact PI
Advisory and Communications Core A$74,715
P01 · FY2017 · GM · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,598,670
P01 · FY2016 · GM · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$539,364
R01 · FY2016 · GM · contact PI
Project 1: Novel Specialized Pro-Resolving Lipid Mediators (SPM) in Resolution of Acute Inflammation$379,120
P01 · FY2016 · GM · contact PI
Core B: Lipid Mediator-SPM Lipidomics$249,550
P01 · FY2016 · GM · contact PI
Advisory and Communications Core A$75,676
P01 · FY2016 · GM · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$53,230
R01 · FY2016 · GM · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,359,745
P01 · FY2015 · GM · contact PI
Controlling cancer with aspirin-triggered stimulation of resolution$506,329
R01 · FY2015 · CA
Carbon Monoxide and Specialized Pro-Resolving Mediators$440,174
P01 · FY2015 · HL · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$432,708
R01 · FY2015 · GM · contact PI
Project 1 : Novel Specialized Pro-Resolving Lipid Mediators$391,285
P01 · FY2015 · GM · contact PI
Core B:SPM-Lipidomics & Metabolomics$293,078
P01 · FY2015 · GM · contact PI
Lipid Mediator Metabolomics$194,918
P01 · FY2015 · HL · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,360,594
P01 · FY2014 · GM · contact PI
Controlling cancer with aspirin-triggered stimulation of resolution$490,642
R01 · FY2014 · CA
Carbon Monoxide and Specialized Pro-Resolving Mediators$440,235
P01 · FY2014 · HL · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$431,528
R01 · FY2014 · GM · contact PI
Project 1 : Novel Specialized Pro-Resolving Lipid Mediators$391,797
P01 · FY2014 · GM · contact PI
Core B:SPM-Lipidomics & Metabolomics$293,466
P01 · FY2014 · GM · contact PI
Lipid Mediator Metabolomics$197,806
P01 · FY2014 · HL · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,313,519
P01 · FY2013 · GM · contact PI
Controlling cancer with aspirin-triggered stimulation of resolution$492,372
R01 · FY2013 · CA
Resolvins, protectins, and chronic pain resolution.$451,119
R01 · FY2013 · NS
Carbon Monoxide and Specialized Pro-Resolving Mediators$429,118
P01 · FY2013 · HL · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$415,838
R01 · FY2013 · GM · contact PI
Project 1 : Novel Specialized Pro-Resolving Lipid Mediators$326,680
P01 · FY2013 · GM · contact PI
Core B:SPM-Lipidomics & Metabolomics$262,484
P01 · FY2013 · GM · contact PI
Lipid Mediator Metabolomics$195,998
P01 · FY2013 · HL · contact PI
Resolvins, protectins, and chronic pain resolution.$78,500
R01 · FY2013 · NS
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,361,099
P01 · FY2012 · GM · contact PI
Novel Mechanisms in Resolution to Harness Inflammation for Reconstruction$624,717
R01 · FY2012 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$467,038
R01 · FY2012 · NS
Carbon Monoxide and Specialized Pro-Resolving Mediators$453,194
P01 · FY2012 · HL · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$430,920
R01 · FY2012 · GM · contact PI
Project 1 : Novel Specialized Pro-Resolving Lipid Mediators$392,294
P01 · FY2012 · GM · contact PI
Controlling cancer with aspirin-triggered stimulation of resolution$384,219
R01 · FY2012 · CA
Core B:SPM-Lipidomics & Metabolomics$293,841
P01 · FY2012 · GM · contact PI
Lipid Mediator Metabolomics$209,998
P01 · FY2012 · HL · contact PI
Resolution Mechanisms in Acute Inflammation: Resolution Pharmacology$1,380,537
P01 · FY2011 · GM · contact PI
Novel Mechanisms in Resolution to Harness Inflammation for Reconstruction$643,459
R01 · FY2011 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$563,006
R01 · FY2011 · NS
Carbon Monoxide and Specialized Pro-Resolving Mediators$455,366
P01 · FY2011 · HL · contact PI
Blood Cell Lipoxygenase Products--Formation and Action$430,726
R01 · FY2011 · GM · contact PI
Project 1 : Novel Specialized Pro-Resolving Lipid Mediators$392,666
P01 · FY2011 · GM · contact PI
Core B:SPM-Lipidomics & Metabolomics$294,113
P01 · FY2011 · GM · contact PI
Lipid Mediator Metabolomics$214,050
P01 · FY2011 · HL · contact PI
Resolvins, protectins, and chronic pain resolution.$51,520
R01 · FY2011 · NS
Specialized Center for Oral Inflammation and Resolution$1,987,960
P50 · FY2010 · DE · contact PI
Mechanism of action of omega-3 fatty acids in brain injury$1,406,161
RC2 · FY2010 · AT
Novel Mechanisms in Resolution to Harness Inflammation for Reconstruction$669,215
R01 · FY2010 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$615,294
R01 · FY2010 · NS
Blood Cell Lipoxygenase Products--Formation and Action$434,093
R01 · FY2010 · GM · contact PI
Mechanism of action of omega-3 fatty acids in brain injury$1,418,175
RC2 · FY2009 · AT
Specialized Center for Oral Inflammation and Resolution$1,140,000
P50 · FY2009 · DE · contact PI
Novel Mechanisms in Resolution to Harness Inflammation for Reconstruction$713,539
R01 · FY2009 · DE · contact PI
Resolvins, protectins, and chronic pain resolution.$602,508
R01 · FY2009 · NS
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$430,676
R37 · FY2009 · GM · contact PI
PHAGOCYTE RESOLVING METABOLISM$309,773
R01 · FY2009 · DK · contact PI
Specialized Center for Oral Inflammation and Resolution$1,790,664
P50 · FY2008 · DE · contact PI
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$416,434
R37 · FY2008 · GM · contact PI
Novel Lipid Mediators in Periodontal Disease Resolution Circuits$305,144
P50 · FY2008 · DE · contact PI
PHAGOCYTE RESOLVING METABOLISM$300,749
R01 · FY2008 · DK · contact PI
Core--Administrative and Communications$119,180
P50 · FY2008 · DE · contact PI
Specialized Center for Oral Inflammation and Resolution$1,790,664
P50 · FY2007 · DE · contact PI
Specialized Center for Oral Inflammation and Resolution$1,349,587
P50 · FY2007 · DE · contact PI
Novel Lipid Mediators in Periodontal Disease Resolution Circuits$537,638
P50 · FY2007 · DE · contact PI
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$414,698
R37 · FY2007 · GM · contact PI
PHAGOCYTE RESOLVING METABOLISM$297,946
R01 · FY2007 · DK · contact PI
Core--Administrative and Communications$213,049
P50 · FY2007 · DE · contact PI
Specialized Center for Oral Inflammation and Resolution$1,844,144
P50 · FY2006 · DE · contact PI
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$412,976
R37 · FY2006 · GM · contact PI
Novel Lipid Mediators in Periodontal Disease Resolution Circuits$316,805
P50 · FY2006 · DE · contact PI
PHAGOCYTE RESOLVING METABOLISM$297,909
R01 · FY2006 · DK · contact PI
Core--Administrative and Communications$126,854
P50 · FY2006 · DE · contact PI
Specialized Center for Oral Inflammation and Resolution$1,843,663
P50 · FY2005 · DE
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$408,392
R37 · FY2005 · GM
Novel Lipid Mediators in Periodontal Disease Resolution Circuits$316,805
P50 · FY2005 · DE
PHAGOCYTE RESOLVING METABOLISM$296,057
R01 · FY2005 · DK
Core--Administrative and Communications$126,854
P50 · FY2005 · DE
Specialized Center for Oral Inflammation and Resolution$1,843,619
P50 · FY2004 · DE
MOLECULAR MECHANISMS IN LEUKOCYTE-MEDIATED TISSUE INJURY$1,162,822
P01 · FY2004 · DE
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$376,892
R37 · FY2004 · GM
Novel Lipid Mediators in Periodontal Disease Resolution Circuits$316,805
P50 · FY2004 · DE
Core--Administrative and Communications$126,854
P50 · FY2004 · DE
MOLECULAR MECHANISMS IN LEUKOCYTE-MEDIATED TISSUE INJURY$1,132,413
P01 · FY2003 · DE
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$376,892
R37 · FY2003 · GM
Neutrophil anti-inflammatory lipid signals$217,043
P01 · FY2003 · DE
MOLECULAR MECHANISMS IN LEUKOCYTE-MEDIATED TISSUE INJURY$1,112,001
P01 · FY2002 · DE
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$376,892
R37 · FY2002 · GM
Oxo-eicosanoid reductase in inflammation resolution$186,686
P01 · FY2002 · DK
MOLECULAR MECHANISMS IN LEUKOCYTE-MEDIATED TISSUE INJURY$1,035,543
P01 · FY2001 · DE
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$376,892
R37 · FY2001 · GM
Neutrophil anti-inflammatory lipid signals$254,615
P01 · FY2001 · DE
Oxo-eicosanoid reductase in inflammation resolution$186,686
P01 · FY2001 · DK
Neutrophil anti-inflammatory lipid signals$185,684
P01 · FY2001 · DE
MOLECULAR MECHANISMS IN LEUKOCYTE-MEDIATED TISSUE INJURY$8,598
P01 · FY2001 · DE
MOLECULAR MECHANISMS IN LEUKOCYTE-MEDIATED TISSUE INJURY$886,055
P01 · FY2000 · DE
BLOOD CELL LIPOXYGENASE PRODUCTS--FORMATION AND ACTION$376,892
R37 · FY2000 · GM
NOVEL LIPID DERIVED SIGNALS--POTENTIAL ANTIINFLAMMATORY MEDIATORS IN ASTHMA$225,945
P50 · FY2000 · HL
Oxo-eicosanoid reductase in inflammation resolution$186,686
P01 · FY2000 · DK
Neutrophil anti-inflammatory lipid signals$0
P01 · FY2000 · DE